Argos Therapeutics

RNA-based dendritic cell therapies for cancer and infectious diseases.

placeDurham, North Carolina, United States calendar_todayFounded 1997 groups120 employees language argostherapeutics.com

Registered entities

Investor mix

31 investors on record; lead investors include Pharmstandard International, Forbion; 3 have since exited.

Investor typeCountShare
Venture capital1445%
Private equity413%
Bank & private debt13%
Other / undisclosed1239%
Coming soon